Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Polish Researchers Cite Rutherrin PDT for Brain Cancer

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Sep 14, 2023 10:12am

167 Views

Post# 35635815

RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

All I know is that Roger was trying to raise 5 million since June and was only able to get about a third of that. Unless another source of funding is imminent, I suspect we are already running on fumes and will be out of cash in a month or so.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record